Explore

Trendline Trendline
Immunome Advances Oncology Pipeline with New Drug Application and Clinical Trials

Immunome Advances Oncology Pipeline with New Drug Application and Clinical Trials

Immunome Advances Oncology Pipeline with New Drug Application and Clinical Trials
Trendline Trendline
Immunome Advances Cancer Therapy Pipeline with New Drug Application and Clinical Trials

Immunome Advances Cancer Therapy Pipeline with New Drug Application and Clinical Trials

Immunome Advances Cancer Therapy Pipeline with New Drug Application and Clinical Trials
Trendline Trendline
Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials

Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials

Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials
Trendline Trendline
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Trendline Trendline
Savara Reports First Quarter Financial Results Highlighting MOLBREEVI Development Progress

Savara Reports First Quarter Financial Results Highlighting MOLBREEVI Development Progress

Savara Reports First Quarter Financial Results Highlighting MOLBREEVI Development Progress
Trendline Trendline
Zai Lab Secures FDA Fast Track for Zocilurtatug Pelitecan in Treating Aggressive Cancers

Zai Lab Secures FDA Fast Track for Zocilurtatug Pelitecan in Treating Aggressive Cancers

Zai Lab Secures FDA Fast Track for Zocilurtatug Pelitecan in Treating Aggressive Cancers
Trendline Trendline
Verastem Oncology to Present at Key Investor Conferences in May 2026

Verastem Oncology to Present at Key Investor Conferences in May 2026

Verastem Oncology to Present at Key Investor Conferences in May 2026
Trendline Trendline
IMMEDIATE Therapeutics Strengthens Team to Advance Ischemic Therapy IMT-358

IMMEDIATE Therapeutics Strengthens Team to Advance Ischemic Therapy IMT-358

IMMEDIATE Therapeutics Strengthens Team to Advance Ischemic Therapy IMT-358
Trendline Trendline
Incyte to Present Over 20 Abstracts at European Hematology Association 2026 Congress

Incyte to Present Over 20 Abstracts at European Hematology Association 2026 Congress

Incyte to Present Over 20 Abstracts at European Hematology Association 2026 Congress
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement
Trendline Trendline
Coya Therapeutics Receives FDA Fast Track Designation for ALS Treatment COYA 302

Coya Therapeutics Receives FDA Fast Track Designation for ALS Treatment COYA 302

Coya Therapeutics Receives FDA Fast Track Designation for ALS Treatment COYA 302
Trendline Trendline
Zai Lab Gains FDA Fast Track for Zocilurtatug Pelitecan in Treating Aggressive Neuroendocrine Carcinomas

Zai Lab Gains FDA Fast Track for Zocilurtatug Pelitecan in Treating Aggressive Neuroendocrine Carcinomas

Zai Lab Gains FDA Fast Track for Zocilurtatug Pelitecan in Treating Aggressive Neuroendocrine Carcinomas